Northern Star Investment Corp. III (NYSE:NSTC) and Northern Star Investment Corp. IV (NYSE:NSTD) announced this morning that both companies have adjourned their extension votes.
Both SPACs intended to hold their meetings on February 24, but have adjourned them until March 1 to further engage with stockholders and solicit additional votes and redemption reversals. Northern Star III and IV have completion deadlines of March 4, and are hoping to gain shareholder approval to extend their timelines until September 4.
Additionally, due to the Inflation Reduction Act of 2022, a 1% U.S. federal excise tax will be imposed on certain repurchases of stock occurring on or after January 1. As a result, any share redemption that occurs after December 31, 2022, in connection with a business combination or extension vote may be subject to the excise tax. Both companies have agreed that if the extensions are approved, then the per share price payable to stockholders exercising their redemption rights will not be reduced by payments required to be made under the Act.
Northern Star III announced the pricing of its upsized $350 million IPO in March 2021. It hasn’t announced a business combination just yet, but aims to combine with a direct-to-consumer target or disruptive e-commerce marketplace with a data-driven business.
Northern Star IV also announced the pricing of its upsized $350 million IPO in March 2021, and also intends to combine with a direct-to-consumer target with a data-driven business.
Both SPACs are led by Chairman and CEO Joanna Coles, CFO James H.R. Brady and President and COO Jonathan Ledecky.
Trailblazer Merger I (NASDAQ:TBMC) has entered into a definitive agreement to combine with data intelligence firm Cyabra at an enterprise value of $70 million. Tel Aviv-based Cyabra provides tools to corporations and governments to identify fake accounts and combat social media disinformation. The combined company is expected to trade on the Nasdaq once the deal...
Chain Bridge I (NASDAQ:CBRG) has entered into a definitive agreement to combine with cannabinoid pharmaceuticals firm Phytanix Bio at a pre-deal valuation of $58 million. Santa Barbara, California-based Phytanix is working to develop bladder and seizure treatments using cannabis-based substances. The combined company is expected to trade on the Nasdaq under the symbol “PHYX” once...
At the SPAC of Dawn A new ripple is expected to come to the market today in the form of Ethereum spot ETFs after the SEC gave final approval to several yesterday. BlackRock, Fidelity, Bitwise, Franklin, and VanEck all received approval for their new funds and all but BlackRock plan to waive fees until they...
Maquia Capital (NASDAQ:MAQC) has entered into a definitive agreement to combine with AI infrastructure firm Velocium at a valuation of $445 million. Miami-based Velocium is developing data center processors designed to be particularly efficient for use by AI applications and Web 3.0. The combined company is expected to trade on the Nasdaq under the symbol...
At the SPAC of Dawn The third week of July brings just three votes and only ARYA IV‘s (NASDAQ:ARYD) is to complete a transaction, but plenty more is turning in SPACland. For one, this week’s anticipated IPO for M3-Brigade V (NASDAQ:MBAV) now looks notably different with 1/2 warrants in its units and its trust overfunded...